AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib...
- Dec 21, 2022
Premia and National Cancer Center Hospital East Announce the Initiation of the LC-SCRUM-AP Genomic..
- Nov 17, 2022
AmoyDx® Pan Lung Cancer PCR PanelApprovedin Japan as a Companion DiagnosticforLUMAKRAS ®...
- Aug 9, 2022
MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek®...
- Apr 20, 2022
Filing Notice for a Manufacturing and Marketing Application for AmoyDx® Pan LungCancer PCR Panel...
- Feb 24, 2022
Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval...
- Jan 14, 2022
AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan
- Aug 17, 2021
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO®
- Jun 30, 2021
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic...
- Jun 24, 2019
PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
- May 31, 2019
LC-SCRUM Japan Expands Genomic Screening Project to Taiwan and Establishes LC-SCRUM Asia